Core Laboratories N.V. Common S (NYSE:CLB).
On September 12 Citigroup left the company rating at “Neutral” and moved down the price target from $120.00 to $116.00. On September 1 analysts at Credit Suisse added the stock to its research portfolio giving it an initial rating of “Neutral” and setting a price target of $115.00.
July 25 investment analysts at Citigroup made no change to the stock rating of “Overweight” but lowered the price expectation to $120.00 from $123.00. Equity analyst JP Morgan released its first research report on the stock with a rating of “Overweight” and a price target of $120.00.
On May 16 Citigroup made no change to the company rating of “Neutral” and raised the price expectation to $123.00 from $115.00.
The company is so far trading unchanged from yesterday’s close of $104.53. Core Laboratories N.V. Common S recently announced a dividend for shareholders that was paid on Monday August 15th, 2016. The dividend payment was $0.550 per share for the quarter which comes to $2.20 on an annualized basis. This dividend represents a yeild of $2.10 which is the dividend as a percentage of the current share price. The ex-dividend date was Thursday the 14th of July 2016.
Shares of the company are trading at $104.53 a tad below the 50 day moving average which is $112.49 and just a bit lower than the 200 day moving average of $117.63. The 50 day moving average went down $-7.96 or -7.08% and the 200 day average went down by -11.13%.
The company’s P/E ratio is 55.45 and the market value is 4.61B. As of the last earnings report the EPS was $1.88 and is expected to be $1.56 for the current year with 44,106,000 shares outstanding. Analysts expect next quarter’s EPS to be $0.42 with next year’s EPS projected to be $2.29.